ban on tirzepatide Compounded GLP-1 ban: What providers need to know TGA proposes ban on injectable

The dual-receptor action is what differentiates tirzepatide from single-receptor GLP-1 agonists like semaglutide

The company said they should be for people living with diabetes and/or obesity, or who are overweight with other related medical conditions.

People online share miracle stories of how much weight theyre losing on Mounjaro, and celebrities like women on The Real Housewives have praised the medication for its weight loss capabilities

Curcumin Support Discover the benefits of Curcumin Support - a premium quality supplement designed to support your health and wellness journey

DIHEXA HGF ( )

But right now, unfortunately, it is unsustainable. The states biggest private insurer, Blue Cross Blue Shield of Massachusetts, also axed coverage of GLP-1 drugs for weight loss this year because the costs were driving up premiums for all members